QualityStocks

[QualityStocks]

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Offers Effective, Innovative Alternative to Physical Auctions as Online Vehicle Trade Flourishes

-To survive, car dealerships have quickly adapted to an online transaction model where the buyer has more control over the process, more options and transparent pricing
-New model includes home deliveries of fully sanitized vehicles for test drives or completed orders
-Online vehicle trading is expected to continue growing, as 49 percent of consumers are ready to buy online and as many as 1.3 million vehicles are expected to be sold annually as soon as 2035
-PowerBand Solutions’ cloud-based platform is a reliable online alternative, offering users complete control over the purchasing process by taking transaction online, streamlining the interactions among all participants and eliminating unnecessary middlemen

COVID-19 has drastically changed the way people buy and sell cars and these changes are here to stay.

Numerous recent reports have shown that post-COVID-19, customers will still want to be able to talk to dealers online and have virtual walks around their car of choice. They will want to schedule test drives online and have a fully sanitized vehicle be brought to their homes for that purpose. If they decide to buy it, they will ask the car to be brought back to their homes for final delivery. Additionally, they already expect great rates and deals on their purchases. And in the post-COVID world, it looks like their expectations will be met. After all, dealerships want to remain on the market, according to a Detroit Free Press report (http://ibn.fm/yw07Q).

These benefits to customers are already starting to become reality thanks to the great efforts of companies like PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA). As customers aren’t overjoyed by the prospect of being physically present at dealership locations, PowerBand Solutions’ cloud-based platform has made it possible to buy, sell, lease and trade vehicles online, with never-seen-before simplicity, speed and cost-efficiency, irrespective of device or location.

The new normal of buying vehicle puts the buyer in control, with more options and transparent pricing. This is the future and dealers simply have to adapt or die, according to industry observers.

An early example mentioned in the Detroit Free Press Report is that of Carter Myers Automotive in Charlottesville, who has seen their online vehicle purchasing grow steadily since the beginning of the outbreak. Home deliveries of new vehicles have reached almost 25% of all of Carter Myers Automotive’s sales, up from less than 5% in mid-March.
But PowerBand takes this to an entirely new level, because it allows consumers to access a far wider market from their smart phones. Even during a pandemic, they can buy, sell, lease, or auction a car from any location.

The development is fully in line with a nationwide and global trend for online automotive transaction alternatives, amid growing demand for safe, technology-powered solutions and an enhanced customer experience. The coronavirus and technology have already made the car buying process more efficient. The driver doesn’t have to leave their home to purchase a car and there are almost never any negotiations because today, cars on lots are priced very affordably. Buyers can save an average of 20% on a vehicle (http://ibn.fm/H08eW).

According to the ‘Digital Commerce 360 Online Vehicle Shopper 2019’ survey, conducted among 1,089 buyers, 49% are willing to purchase a new vehicle entirely online (http://ibn.fm/bAaJ9). According to Frost & Sullivan, consumers may purchase as many as 1.3 million vehicles annually online as soon as 2035 (http://ibn.fm/My8oz). And nearly 90% of Americans report they dislike the car dealership experience, noting they feel anxious or uncomfortable in dealership settings.

PowerBand is positioned to capitalize on these trends by disrupting the antiquated business model of the automotive industry, replacing distrust and confusion with transparency, access to information and ease of use. Developed by a team of experienced automotive, technology and finance experts, PowerBand Solutions’ platform empowers the consumer to self-direct a transaction, by streamlining the interactions among all participants and eliminating unnecessary middlemen, all from a smart phone.

The company is currently rolling out its platform across the United States and to this end, it has partnered with Source Digital, a pioneer in immersive commerce through the use of digital media platforms and video content on the internet (http://ibn.fm/1WEff). This unique campaign will use Source’s patented technology to promote PowerBand’s platform inside popular video content with various channels and influencers in the U.S.

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

QualityStocksNewsBreaks – CloudCommerce, Inc. (CLWD) Eyes Strong Trend to Digital Media, Acceleration Appears to be Helped by Pandemic

CloudCommerce (OTC: CLWD), a leading provider of digital advertising solutions, today announced that in spite of the economic downturn caused by the COVID-19 pandemic, the Company has recently increased revenue from its existing client base and added new clients within the past few weeks. “As was the case with most business leaders, our management team was concerned about the economic headwinds caused by the COVID-19 pandemic,” Andrew Van Noy, CEO of CloudCommerce, stated in the news release. “However, I am pleased to announce that our recent sales efforts have resulted in newfound revenue growth for CloudCommerce. As the economy begins to re-open, we are also seeing existing clients ramp up their digital advertising budgets. The strong trend to digital media and away from traditional media appears to be accelerating – helped by the pandemic. We look forward to helping more businesses leverage digital advertising to be more competitive and successful in a post-pandemic world.”

To view the full press release, visit http://ibn.fm/bkJaU

About Cloud Commerce, Inc.
CloudCommerce, Inc. (CLWD) is a leading provider of digital advertising solutions. Its flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to, what to say to them, and how to market to them. CloudCommerce does this by applying advanced data science, behavioral science, artificial intelligence, and market research techniques to discover, develop and create custom audiences for highly targeted digital marketing campaigns. CloudCommerce was Ranked Number 235th Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500(TM). To learn more about CloudCommerce, please visit www.CloudCommerce.com

NOTE TO INVESTORS: The latest news and updates relating to CLWD are available in the company’s newsroom at http://ibn.fm/CLWD

[QualityStocks]

Singlepoint Inc.’s (SING) 1606 Original Hemp Cigarettes See Record Sales Rise

-SinglePoint Inc. announced that its range of pre-rolled hemp cigarettes, 1606 Hemp Direct, saw revenues growth by 133% quarter-on-quarter
-CBD-infused cigarettes target smokers looking for smoother alternative to tobacco, with CBD-infused product market set to reach $23.7 billion by 2023
-1606 Hemp Direct cigarettes currently sold by network of 400 retailers across 19 states, with the company seeking to expand its number of vendors in near future
-SinglePoint forecast that its 1606 Hemp product could generate between $2.75 million – $5.5 million in annual revenues per 1,000 stores

As public opinion of nicotine cigarettes continues to sour with each increasingly health-conscious generation, consumers are seeking safer alternatives to smoking—and hemp cigarettes have taken center stage. SinglePoint (OTCQB: SING), a publicly traded company dedicated to acquiring businesses focused on emerging technologies, recently reported that its hemp cigarette brand 1606 Original Hemp had posted a remarkable 133% growth in sales this quarter relative to the previous one—a growth figure that points to the public’s increasing interest in the safer alternative (http://ibn.fm/J7Lfv).

The 1606 Original Hemp product range (http://ibn.fm/G0oG9), which consists of pre-rolled organically cultivated hemp cigarettes, was launched December 2019 at the MJBizCon Conference in Las Vegas (http://ibn.fm/BZzd3) targets a rapidly growing market of smokers looking for smoother alternatives to conventional tobacco products. Since then and within a few short months, the product has gained widespread popularity, with over 400 retailers across 19 states now marketing the brand.

SING’s hemp cigarette offering has been meticulously designed to be both nicotine and tobacco-free and is crafted from broad spectrum American grown, harvested and cured hemp flower. Moreover, with less than 0.3% THC and nearly 20% cannabinoid oil (CBD) content, the pre-rolled cigarettes have quickly consolidated a domineering position within the largely untapped yet rapidly growing smokable hemp market segment. In an insightful recent survey of 5,000 US-based CBD users carried out by the Brightfield Group, tobacco users were revealed to have increasingly turned to CBD products in an effort to quit smoking, with 24% opting to smoke hemp cigarettes as a replacement to cigarettes. Meanwhile, 41% of former smokers were found to have entirely replaced traditional smoking with hemp-derived CBD (http://ibn.fm/It4oF).

The use of industrial hemp products has gained particular prominence in recent years, with a June 2019 market research report by MarketsandMarkets projecting the sector to grow in size from $4.6 billion in 2019 to $26.6 billion by 2025, recording a compound annual growth rate of 34.0% during the period (http://ibn.fm/V01Qw). Meanwhile, a recent study showed that nearly 4 million Americans were choosing to consume non-psychoactive cannabinoid oil (CBD) infused products (http://ibn.fm/mZ8ya), with CBD-infused topical and supplement products now found across a range of mainstream retailers, including the likes of Abercrombie & Fitch and Kroger.

SinglePoint Inc. has chosen to distribute its pioneering product in a novel manner, opting to do so through a targeted direct-to-store (DSD) sales initiative rather than through a conventional distributor. The initial phase of the DSD sales strategy has been largely centered on self-generated store acquisition, during which the company sought to contact a number of retail accounts—ranging from convenience stores to smoke shops scattered across the United States—in a bid to gain at least 250 retailers marketing their products. Within a few months, the company announced that they had already put in place a network of 400 stores across 19 states, surpassing their 250-store goal in a matter of weeks with a number of the new retail accounts reportedly placing reorders for 1606 Original Hemp product.

The growth in scale within SinglePoint’s distribution network has been increasingly apparently in recent weeks. In the last month alone, orders for 1606 Original Hemp have risen by 64% relative to the previous four weeks while average sale sizes have grown by 42%. However, the company’s management has recently revealed an ambitious plan to embark on a new growth phase focused around the acquisition of 2,500 new vendors while simultaneously seeking to increase and enhance the reorder rate from existing accounts. In a statement, SinglePoint announced its anticipation of the 1606 Hemp product generating $2.75 million to $5.5 million in annual sales revenue per 1,000 active accounts (http://ibn.fm/apH9p). That figure could prove to be even more remarkable given that it could single-handedly enable SinglePoint to double its 2019 revenues of $3.34 million.

For more information, visit the company’s website at www.Singlepoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

[QualityStocks]

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Engages Toronto-based Dalriada to Advance NCE IP Portfolio

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced its selection of Toronto-based Dalriada Drug Discovery Inc. (“Dalriada”) to advance its new chemical entity (“NCE”) IP portfolio as it pertains to ketamine and psilocybin/psilicin molecular scaffolds. According to the update, Dalriada, a leading contract research organization (“CRO”) in the drug discovery space, will lead Champignon’s new drug discovery programs in the NCE arena and further provide integrated R&D support to accelerate the Company’s existing preclinical assets and ongoing development of proprietary delivery platforms. “It is with great pleasure that we welcome the Dalriada group to Champignon,” Champignon Special Advisor Dr Joseph Gabriele stated in the news release. “Dalriada’s expertise in medicinal chemistry will be a monumental addition to Champignon’s innovative diverse formulation platforms by their expertise in the synthesis of molecules, including existing psychedelics (ketamine, psilocybin and MDMA), as well as novel new psychedelic-like molecules. This synergistic collaboration will differentiate Champignon from other companies in the psychedelic space by boosting our ability to maintain an inhouse infrastructure for the clinical delivery NCEs.”

To view the full press release, visit http://ibn.fm/SERtM

About Champignon Brands Inc.
Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

[QualityStocks]

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Secures Utah Department of Insurance Approval of RPG Application

InsuraGuest Technologies (TSX.V: ISGI) today announced that the Utah Department of Insurance has found the Company’s wholly owned U.S. subsidiary InsuraGuest Risk Purchasing Group, LLC (“RPG”) to be in compliance with the requirements set forth in section 31A-15-201 of the Utah Code (the Risk Retention Groups Act). As of the acceptance date of June 4, 2020, RPG is registered and authorized to do business in Utah, with the Utah Insurance Department. “This is the last piece of the puzzle we needed to complete our Master Policy for our RPG’s Hospitality Liability coverages,” Douglas Anderson, chairman and CEO of InsuraGuest, stated in the news release. “Having the Master Policy allows our RPG to issue certificates directly to our members, streamlining the process that would otherwise require the issuance of individual polices through our underwriter. It also gives us the power to complete our integration with vacation rental property management system Hostfully, which we expect to finish and launch in the very near future.”

To view the full press release, visit http://ibn.fm/EOPnd

About InsuraGuest Technologies Inc.
Harnessing the Power of Technology to Reinvent Insurance
InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF) is an insurtech (insurance + technology) company that’s disrupting the insurance landscape by utilizing its proprietary software platform to deliver digital insurance to multiple sectors. It is transforming the way insurance is delivered with the revolutionary idea that insurance should be bought, not sold. For more information, visit the Company’s website at www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

[QualityStocks]

QualityStocksNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Chairman and CEO to Present at the MoneyShow June Virtual Event

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that it will present at the MoneyShow June Virtual Event at 12:50 p.m. EDT on Wednesday, June 10, 2020. According to the update, Genprex’s CEO and Chairman, Rodney Varner, will deliver a company overview and provide updates on its product pipeline, including its lead drug candidate, Oncoprex(TM) immunogene therapy, which received Fast Track Designation from the Food and Drug Administration for its combination therapy with AstraZeneca’s Tagrisso(R). He will also provide an overview of Genprex’s in-licensing of a preclinical gene therapy candidate that has the potential to cure Type 1 and Type 2 diabetes. Interested parties may register for Varner’s live presentation by visiting the following link: http://ibn.fm/5cKao.

To view the full press release, visit http://ibn.fm/TEYbv

About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)). For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

[QualityStocks]

QualityStocksNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) CEO to Present at the Virtual Summer Summit Online Event

Exro Technologies (CSE: XRO) (OTCQB: EXROF) today announced that its CEO, Sue Ozdemir, will present at the Virtual Summer Summit online event on June 10, 2020. According to the update, Ozdemir will provide an update on the Company’s technology and rapidly advancing commercialization strategy, which now includes five partnerships with companies in the mobility sector that are using Exro’s patented coil switching to dramatically improve the performance and sustainability of power trains. Investors and interested parties are invited to visit the following link to register for the Exro presentation, scheduled to take place at 10:55 a.m. Eastern Time on Wednesday, June 10: http://ibn.fm/fgq7f

To view the full press release, visit http://ibn.fm/pHXap

About Exro Technologies Inc.
Exro is a Clean Tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced motor control technology, its “Coil Driver,” expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real-time so that torque demand and efficiency are optimized.

The limitations of traditional electric machines and power technology are becoming more evident. In many increasingly prominent applications, traditional methods cannot meet the required performance. This means either oversizing the equipment, adding additional motors, or implementing heavy mechanical geared solutions. Exro offers a new solution for system optimization through implementation of the technology which can yield the following results: increased drive cycle efficiency, reduced system volume, reduce weight, expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed.

For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

[QualityStocks]

QualityStocksNewsBreaks – ISW Holdings (ISWH) Expands Home Healthcare Operations to Meet Rising Need

International Spirits & Wellness Holdings (OTC: ISWH) (“ISW Holdings”), a top-tier brand incubator operating in the spirits, CBD-infused products, and home healthcare markets, recently announced the expansion of its home healthcare segment to multiple new major metropolitan areas in Nevada, New Mexico, Arizona and Florida. “Home Healthcare has been responsible for the bulk of our revenues over the past three quarters, and we are uniquely well-positioned to expand further to meet this dramatic new need,” ISW Holdings president Alonzo Pierce stated in the news release. “The emergence of COVID-19 as a burgeoning pandemic, now beginning to surge as an outbreak in the US, represents a critical opportunity for this Company to step up the plate and deliver much-needed services to a wider consumer base. This is a move we had been planning as of late 2019. But the anticipated jump in demand for home healthcare due to the COVID-19 outbreak has moved up our timeline and we are working to get up and running in these new communities as rapidly as possible.”

To view the full press release, visit http://ibn.fm/Ol7bb

About ISW Holdings
ISWH is a diversified brand incubator with diverse operational interests, including commercial-stage operations in the spirits, CBD, and home healthcare markets, and development-stage operations in the logistics and supply chain and renewable energy markets. Based in Nevada, the company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH has established itself as a health and wellness leader with a focus on reshaping the CBD products and home healthcare markets through state-of-the-art technology and execution. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace with VOLUM. For more information, visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

[QualityStocks]

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Utilizes D&P Holdings’ $10M Commitment to Advance Cloud-Based Vehicle-Transaction Platform

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) recently secured an additional $600,000 from Texas-based D&P Holdings Inc. to offer its platform that provides virtual transactions to consumers and automotive dealers in the United States. An article discussing the company reads, “The capital injection of $600,000 is part of D&P’s ongoing commitment to invest up to $10 million in PowerBand Solutions US Inc., a wholly owned subsidiary of PowerBand Solutions. According to D&P CEO John Armstrong, his company remains unwavering in its commitment to invest at least $10 million in the platform’s development. ‘We are confident PowerBand’s virtual-transaction platform will greatly assist the automotive industry in recovering from the COVID-19 pandemic by empowering consumers and dealers to buy, sell, lease and trade cars and trucks from any remote location,’ Armstrong added. . . . D&P, which works directly with more than 850 dealerships in all 50 states, is one of the United States’ largest administrators of automotive warranty and insurance products. To date, it has completed $3.3 million of its $10 million investment into PowerBand US, which will be available as needed.”

To view the full article, visit http://ibn.fm/BKkxQ

About PowerBand Solutions Inc.
PowerBand Solutions, listed on the TSX Venture Exchange and OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand’s integrated, cloud-based transaction platform facilitates transactions among consumers, dealers, funders and manufacturers (“OEMs”). The platform enables these entities to buy, sell, trade, finance and lease new and used, electric and nonelectric vehicles on smartphones or other online digital devices from any location. PowerBand’s transaction platform — trademarked under DRIVRZ — is being made available across North American and global markets. For more information, visit www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

QualityStocksNewsBreaks – National Storm Recovery (NSRI) Prepares to Provide Storm-Recovery Solutions as Storm Season Approaches

National Storm Recovery (OTC: NSRI), a leading provider of environmentally beneficial solutions for tree and storm-waste disposal, has three substantial agreements in place as it gets ready for the 2020 storm season. A recent article discussing the company reads, “In an industry where need for essential services is rising, the contracts NSRI already has in place is a strong indication of the company’s value and credibility. On July 1, 2019, NSRI entered into a three-year agreement with one of the largest waste disposal companies. This agreement allows NSRI to lease the disposal company’s yard-waste facility to operate NSRI’s biomass recycling facility in Apopka, Florida. The facility’s grand opening took place on October 2, 2019 (http://ibn.fm/VNhaa). . . . Furthermore, NSRI was awarded a three-year contract with two one-year renewals from the town of Oakland, Florida, on August 14, 2019. This contract calls for emergency debris and tree-removal services. . . . In addition, NSRI was awarded a contract on September 10, 2019, as the primary contractor for the Orange County [Florida] Public Schools Tree Trimming and Removal Services. This contract is for a three-year term, also with two one-year renewals. The agreement encompasses 267 properties. These properties include schools, administrative sites and technical colleges as well as maintenance facilities.”

To view the full article, visit http://ibn.fm/GTCCn

About National Storm Recovery Inc.
National Storm Recovery, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company and its Sustainable Green Team’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and are positioned for rapid growth from the resulting synergistic opportunities identified. The company’s client base includes governmental, residential and commercial customers. For more information, visit the company’s website at www.NationalArborCare.com.

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

[QualityStocks]

Vivos Therapeutics Inc. is “One to Watch”

-Obstructive sleep apnea affects millions of people of all ages. It is estimated that OSA costs the US economy $165B annually. The Vivos technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated hundreds of millions of people globally who suffer from OSA.
-As dentists have hundreds of patients of all ages suffering from OSA, the Vivos System presents a multi-million dollar revenue opportunity for dental practices.
-Vivos is helping address challenges throughout the world, reducing the overall cost of health care by focusing on a prevalent condition which is linked to many of the most expensive health care problems.
-The Vivos System is thought to be the most significant breakthrough in OSA treatment since CPAP.
-The system’s treatment time is a fraction of that of its alternatives—patients can find lasting relief in a matter of months, eliminating the need for surgery or a lifetime of therapy.
-Vivos® Integrated Practices are supported by a network of clinical, practice and market advisors who provide guidance, collaboration, various capacities of coaching, and market intelligence in support of growth and distribution.

Headquartered in Denver, Colorado, Vivos Therapeutics Inc. is an emerging global leader in the treatment of obstructive sleep apnea (OSA), a debilitating condition affecting nearly 1 billion people worldwide. The company utilizes proprietary, ground-breaking technology, a proven go-to-market strategy, and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep.

At the core of Vivos’ mission to eradicate OSA is the Vivos System®, a revolutionary clinical breakthrough in the treatment of sleep apnea caused by craniofacial anatomy development. The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health care providers.

In support of its growth strategy, Vivos has established FDA-approved and registered manufacturing facilities in the U.S., Canada and Asia.

Market & Technology Overview
Craniofacial developmental deficiencies, such as underdeveloped upper and lower jaws, are the leading cause of OSA. According to a 2019 analysis from researchers at the University of California, San Diego, an estimated 81 million adults in North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients, with approximately 54 million adults affected, according to the report.

Registered with the FDA as a Specification Developer, Vivos develops and markets a number of oral appliances. Its technology represents the first non-surgical, non-invasive and cost-effective solution for the estimated hundreds of millions of people globally who suffer from OSA.

Vivos integrates its specially designed, customized appliances into a patient-specific, multi-disciplinary clinical protocol, giving trained dental and medical providers the tools and roadmap needed to address certain craniofacial conditions that have proven to be associated with sleep-disordered breathing—including OSA.

The system’s treatment protocol involves collaboration between physicians, specially trained dentists who have received advanced training in craniofacial sleep medicine, and additional health care providers. Vivos-trained clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. The company’s oral appliances have shown to be effective in over 15,000 patients successfully treated worldwide by approximately 1,350 trained dentists.

A New Paradigm in Sleep Medicine
Vivos’ proprietary system poses the potential to be the biggest breakthrough in OSA treatment since CPAP.

Designed to promote correct growth and development of the hard and soft tissues surrounding and compromising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which comprise and shape the human airway. The system uses Pneumopedics®, the natural process induced by Vivos biomimetic technology to widen and expand the patient’s airway, allowing for proper breathing through the nose, effectively addressing the root cause of OSA.

This patented technology offers benefits over CPAP and other oral appliances in its ability to achieve results relatively quickly—in about 18 to 24 months or less—at a lower cost, and without the need for lifetime intervention in most patients. It is believed to be the first effective, non-surgical, non-invasive and potentially long-lasting solution to eradicating OSA.

Strategic Partnership
A cooperative agreement with Benco Dental, the largest family-owned dental distributor in the United States, broadens the reach of the Vivo System. This partnership ensures that all dentists in the United States have access to Vivo’s patented system, on par with Vivo’s vision to provide clinicians with the tools to provide the best alternative solution to treat OSA and well-aligned with Benco’s commitment to evolve the dentistry industry by empowering clinicians with innovative treatment options.

Leadership
Kirk Huntsman – CEO, Director
With experience in strategic development, technology acquisition and product planning, key talent recruitment, and target market prioritization, Huntsman brings a broad vision paired with leadership and strategic planning skills. He has significant start-up experience in a diverse range of market sectors, including medical devices, dental management, dental practice valuations and transitions, multi-location retail, financial and capital formation, consulting, outsourced services, imports and exports (China), medical services, and software and technology.

Dr. Dave Singh – Founder, Director
A doctor three times over in dental medicine, craniofacial development, and orthodontics, Dr. Singh was educated primarily in England and has lectured in North America, Europe, Asia, and Africa. The Global Summits Institute recently named Dr. Singh as one of the Top 100 Doctors in Dentistry.

For more information, visit the company’s website at www.VivosLife.com

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics are available in the company’s newsroom at http://ibn.fm/VVOS

[QualityStocks]

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Leveraging Thermal Imaging, AI Expertise in Development of Solution to Detect COVID-19 Symptoms

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it has started developing a mass screening solution for the detection of COVID-19 symptoms based on visible-light and thermal cameras. According to the update, the Company has submitted a patent application to the U.S. Patent and Trademark Office for a system and method for detection of people infected with COVID-19. “The COVID-19 pandemic has created new challenges for public safety, prioritizing the prevention of another pandemic outbreak as the world begins to resume normal activities. Our extensive experience with thermal imaging and AI can be invaluable when applied to a detection solution for early symptoms of the coronavirus. Several prospective customers have already expressed interest in evaluating our unique technology,” Foresight CEO Haim Siboni said in the news release. “Foresight will continue to work with its multinational collaborators towards the development of automotive vision systems enabling obstacle detection in harsh weather and lighting conditions.”

To view the full press release, visit http://ibn.fm/WYEeB

About Foresight
Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the Company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.

The Company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

[QualityStocks]

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Integral in Shift Towards Data-Driven Marketing

-SRAX’s BIGtoken platform gains relevance on heels of renewed focus on data-driven marketing
-BIGtoken recently launched various new initiatives, including use of sponsored surveys, Lightning Insights, sponsored actions and more
-Kraft’s recent BIGtoken-powered marketing campaign enjoyed 6.6% return on ad spend, far outpacing competing advertising campaigns launched by rivals
-The Publicis Groupe published its second study using BIGtoken’s Lightning Insights tool, highlighting platform’s quick, efficient ability to generate customer insights

In late 2014, UK cell provider Three introduced its award-winning ‘Holiday Spam’ campaign, promoting the mobile company’s roaming data offering which enabled customers to use their phones abroad at no extra cost (http://ibn.fm/6nIhv). The ad campaign featured people ‘spamming’ their friends with their holiday snaps, a concept which resulted from the company’s costly and painstaking investigation into people’s behavior while on vacation – a form of research which SRAX Inc.’s (NASDAQ: SRAX) proprietary BIGtoken platform has now appropriated into an efficient and accessible service offering. The rise of data-driven marketing and the ability to personalize and launch targeted ad campaigns has become critical in improving ad content quality and driving customer engagement. Moreover, it has also grown in significance as a result of a renewed focus by cost-conscious marketers in to their return on ad spends (ROAS). With the use of SRAX’s BIGtoken offering, companies are now able to tap into the platform’s 16.7 million subscribers in an instantaneous fashion – deriving invaluable and oftentimes otherwise inaccessible customer insights and feedback quickly and efficiently.

The BIGtoken platform was initially conceptualized as a means of enabling customers to monetize their data by marketing its access to interested counterparties. Advertisers were able to receive high-quality, targeted data while users were able to control what data was sold to whom, gaining compensation in return. However, the current reach and abilities of the platform far exceed its original intentions. Over the past two quarters, SRAX has launched a number of new initiatives within its proprietary offering, including the dissemination of sponsored surveys, Lightning Insights, insights-driven media as well as sponsored actions – all of which have contributed to the platform’s dramatic increase in monetization in recent months.

Leading up to the 2019 holiday season, global food & beverage giant Kraft Heinz Co. approached SRAX for assistance with its newest marketing campaign, one which would be tailored towards women located in a certain area and professing specific interests. Through the use of over 100 proprietary data points, SRAX’s BIGtoken platform was able to formulate a target audience for Kraft’s campaign which met the company’s desired criteria. The campaign was a notable success, resulting in a 6.6% ROAS for Kraft (http://ibn.fm/M6bc2). Kraft’s marketing campaign success was even more remarkable given that it was run concurrently with two other advertising initiatives, led by Walmart and Evite respectively, both of which failed to produce positive returns. Within an extremely competitive consumer packaged goods (CPG) industry, BIGtoken’s insights were instrumental in contributing to the marketing campaign’s success and driving new consumer activations.

“BIGtoken has evolved from a consumer opt-in data platform for advertising activation to a full-service marketing stack,” said co-founder of BIGtoken Kristoffer Nelson. (http://ibn.fm/cneW5). “Beginning with audience insights, marketers can discover profound insights about their target audience to activate against. From here, new insights and learnings are applied inflight to improve performance. And once the campaign concludes, locations and sales measurements are applied to further learn, optimize and iterate.”

However, BIGtoken’s abilities have not been limited to determining target audiences. During the COVID-19 outbreak, marketers and data analysts found themselves blindsided, unable to gain insights into their end consumers’ rapidly changing behavior as a significant proportion of their conventional tools were rendered largely useless by nation-wide ‘shelter at home’ orders.

Publicis Groupe, one of the world’s largest advertising firms, seized the opportunity to carry out a unique study utilizing BIGtoken’s Lightning Insights service, examining consumption patterns and customer behavior surrounding the Mother’s Day celebrations in May (http://ibn.fm/b3uRP). The study found that 84% of respondents had celebrated Mother’s Day 2020 in some way, with over 68% of respondents sending gifts, gift cars, or food to their loved ones – the majority of whom chose to do so through online means.

Marketers are increasingly able to use BIGtoken to gain rapid and insightful feedback into their target consumer group’s consumption habits, their planned purchases as well as their preferred acquisition methods. With global consumer brands increasingly on the lookout for newer and more creative ways to interact with their potential consumers (http://ibn.fm/6y2Vx), SRAX’s BIGtoken platform and the valuable insights generated by its captive subscriber base could find itself in greater demand than ever anticipated.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

[QualityStocks]

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Changes Format of 2020 Annual Stockholders Meeting to Virtual Webcast

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that, due to the current impact of the COVID-19 pandemic and limitations within the state of New Mexico on all non-essential gatherings of individuals, it has changed the format of its annual stockholders meeting. According to the update, the 2020 meeting will be in the format of a virtual webcast, and Sigma Labs invites stockholders to participate remotely. The meeting is scheduled to take place at 10:00 a.m. Mountain Time on June 15, 2020. Interested parties may register to attend at http://ibn.fm/Gh7BU.

To view the full press release, visit http://ibn.fm/HC1F0

About Sigma Labs
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

[QualityStocks]

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) President Discusses Online Solar Purchasing Platform and 1606 Hemp Expansion on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint President Wil Ralston discussed the company’s implementation of an online purchasing platform to streamline the process for solar customers. The interview also covers expansion of the company’s 1606 Hemp brand, which is now sold in over 400 stores. “We’re continuing to push forward on 1606,” Ralston stated in the interview. “We’ve seen great success from our campaign where we brought in multiple different sales reps who’ve been calling all around the nation and onboarding new accounts.”

To view the full press releases, visit http://ibn.fm/FEmfV and http://ibn.fm/EZEYI

About SinglePoint, Inc.
Founded in 2011, SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

[QualityStocks]

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Provides Business Update on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives offering insights into various companies and their operations and future outlooks. Among other highlights, this week’s episode featured CEO Warren Wang as he announced that the company recently received government stimulus funding. “I’m so glad that we still have 60 employees, we still have a big payroll,” CIIX CEO Warren Wang stated in the interview. “We received the government money and it temporarily stabilized our balance sheet.”

To view the full press release, visit http://ibn.fm/Lg93E

About ChineseInvestors.com Inc.
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company by providing (a) real-time market commentary, analysis and educationally related services in both traditional and simplified Chinese language character sets; (b) advertising and public-relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health-related products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

[QualityStocks]

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New CEO

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. An article discussing the company reads, “In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. . . . ‘My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,’ McIntyre stated in a news release. ‘The clinical infrastructure, complementary asset base and human capital that Champignon has acquired leaves me very confident we will provide life-changing treatments for persons with depression, all the while contemporaneously rewarding our investor base.’”

To view the full article, visit http://ibn.fm/U4XeF

About Champignon Brands Inc.
Champignon Brands is focused on the formulation and manufacturing of novel ketamine, anesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The company is pursuing the development and commercialization of rapid-onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or standalone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

[QualityStocks]

QualityStocksNewsBreaks – Why Kingman Minerals Ltd. (TSX.V: KGS) Is ‘One to Watch’

Canada-based Kingman Minerals (TSX.V: KGS) is engaged in the acquisition, exploration and development of gold and silver properties in North America. An article discussing the company further reads, “Kingman Minerals is focused on enhancing shareholder value as it continues exploring potential assets and acquiring strategic gold targets. The company recently commissioned mining consulting services company Burgex Mining Consultants Inc. to complete two underground gold-exploration programs in the historic Rosebud Mine. Burgex specializes in mineral exploration, mining claim staking, landman services, mining consulting, and the access and documentation of abandoned mine sites throughout the Western United States and the world. Burgex’s founders have been active in the industry since 2007 and have identified, secured and consulted on hundreds of thousands of acres of mineral properties spanning a wide range of mineral commodities with billions of dollars’ worth of resources and reserves. The Burgex team has been featured in ‘Forbes’ Magazine as well as on the Discovery Channel and other outlets. Burgex is at the vanguard of industry advancements in safely accessing difficult vertical abandoned mine workings and continues to pioneer new mineral-exploration methods with strategic partners throughout the United States and the world.”

To view the full article, visit http://ibn.fm/tPVoW

About Kingman Minerals Ltd.
Kingman Minerals is currently engaged in the business of precious-metal mineral exploration for the purpose of acquiring and advancing nongrass-roots mineral properties located in mining friendly jurisdictions of North America. The Mohave Project is located in the Music Mountains in Mohave County, Arizona, and is comprised of 20 lode claims that are inclusive of the past-producing Rosebud Mine. High-grade gold and silver veins were discovered in the area in the 1880s and were mined mainly in the late 1920s and 1930s. Underground development on the Rosebud property included a 400-foot shaft and approximately 2,500 feet of drifts, raises and crosscuts. For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

[QualityStocks]

PowerBand Solutions Inc.’s (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Platform Meets Used-Car Buyers’ Demands for Enhanced Tech, Experience

-The used-car segment is twice as big as the new-car market, and digitally savvy consumers are looking for a faster, more transparent purchasing process
-Used-car buyers tend to research a new purchase online and rely less on in-person salespeople
-PowerBand Solutions’ cloud-based platform is a reliable online alternative to the dealership experience, offering users complete control over the purchasing process by streamlining the interactions among all participants and eliminating unnecessary middlemen

The automotive industry market has been in a state of flux, with every aspect experiencing disruption from driverless vehicles to artificial intelligence. Customer expectations for the market have been raised as technological innovation advances. Digitally savvy customers, who have come to expect personalized, flexible and seamless interactions during the purchase experience, are already changing how automobiles are bought and sold – especially when it comes to used vehicles. Platforms like PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) meet this growing demand for flexible and seamless interaction, enabling users to buy or sell cars with never-seen-before ease and efficiency.

According to McKinsey & Company research, the digital revolution is disrupting used-car retailing by focusing not only on technology but also on the importance of the customer experience. Online car providers are already empowering digitally-savvy customers in this respect, offering a range of complete services that enhance the purchasing experience (http://ibn.fm/dGhVf).

More specifically, online providers offer extensive vehicle data and effective search tools to find the right car (desired by 64 percent of buyers), complete end-to-end purchasing capabilities (desired by 59 percent of buyers), and unique delivery options (desired by 28 percent of online buyers).

According to the McKinsey research, titled ‘Used cars, new platforms: Accelerating sales in a digitally disrupted market’, used-car buyers spend about 40 percent more time researching online during the buying process than new-car buyers. Part of the reason for this might be that only 8 percent of used-car buyers rely solely on in-person salespeople when purchasing a vehicle; the rest make decisions based on their own prior research. Used-car buyers expect a faster, more transparent, and more convenient process. Introducing digital tools to simplify and shorten the process will improve customer satisfaction and insurance penetration rates.

As more used-car customers expect the same seamless digital service they receive throughout other retail markets, used-car retailers will adapt to remain competitive and protect profits, as well as finance and insurance margins. To do so, retailers must find opportunities to leverage the digital-oriented nature of used-car buyers and their desire for advanced technology. Adapting to the new demands will be beneficial to car traders and dealerships, as the used-car market is growing exponentially in the United States and is already twice the size of the new-car segment. According to McKinsey, Americans buy 39.4 million used cars each year, compared to 17.3 million (data from 2018), and the trend is likely to continue over the next five years.

The results of the McKinsey research confirm the trend of a rising demand for online vehicle trading alternatives. According to the ‘Digital Commerce 360 Online Vehicle Shopper 2019’ survey, conducted among 1,089 buyers, 49% are willing to purchase a new vehicle entirely online (http://ibn.fm/ETcN4). According to Frost & Sullivan, consumers may purchase as many as 1.3 million vehicles annually online as soon as 2035 (http://ibn.fm/xtLMq), and nearly 90% of Americans report they dislike the car dealership experience, noting they feel anxious or uncomfortable in dealership settings.

PowerBand is positioned to capitalize on these trends by disrupting the antiquated business model of the automotive industry, replacing distrust and confusion with transparency, access to information and ease of use. Developed by a team of experienced automotive, technology and finance experts, PowerBand Solutions’ platform empowers the consumer to self-direct a transaction, by streamlining the interactions among all participants and eliminating unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles with never-seen-before simplicity, speed and cost-efficiency from their smart phones or other devices, irrespective of their location.

The company is currently rolling out its platform in the United States and to this end, it has partnered with Source Digital, a pioneer in immersive commerce through the use of digital media platforms and video content on the internet (http://ibn.fm/zt4Na). This unique campaign will use Source’s patented technology to promote PowerBand’s platform inside popular video content with various channels and influencers in the U.S.
For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

Trxade Group Inc.’s (NASDAQ: MEDS) Pharmaceutical Marketplace Continues Profitable Expansion

-Revenues for Q1 2020 up 46% year over year
-Gross profit of 75% shows viability of business model
-Close to 12,000 independent pharmacies now using online marketplace

Stellar results recently reported by Trxade Group Inc. (NASDAQ: MEDS) are an indication that, increasingly, independent pharmacies, drug distributors and manufacturers are turning to the company’s web-based purchasing platform. At $2.2 million, revenues for Q1 2020 were up 46% year over year, with gross profit coming in at an extraordinary 74.4%. Now that more than 11,900 pharmacies are using the marketplace, Trxade seems set to fulfil its mission of signing most of the nation’s 24,000 independent pharmacies. If so, the company’s combined annual purchasing power of over $92 billion would make Trxade the nation’s premier marketplace for America’s vital pharmaceutical supplies.

Both for patients and pharmacists, the pharmaceutical marketplace that Trxade provides is a welcome adjunct to the healthcare sector. The online platform not only identifies the best available prices for prescription drugs, a constant concern of patients, but helps pharmacists avoid negative reimbursement costs, which reduce their profit margins. The fact that close to half of the nation’s independent pharmacies are already using the Trxade marketplace appears to be proof that the company is offering a superior solution to reduction of margins due to Prescription Benefit Managers (PBMs) via cost containment and better pharmaceutical accessibility.

Once unknown in the healthcare financing landscape, PBMs now dominate the U.S. health sector. Many PBMs have revenues that exceed those of the top pharmaceutical manufacturers. For example, Express Scripts reported revenue of $100 billion in 2017, about twice as much as Pfizer, which is the largest pharmaceutical company in the world. Incredible as it may seem, the distribution of pharmaceuticals is a much more lucrative business than the manufacture of pharmaceuticals. Indeed, distribution margins also exceed those earned by pharmacies at the retail level.
This isn’t the way it was supposed to work. The introduction of PBMs, third-party administrators of prescription drug programs, was intended, among other things, to reduce the purchase costs of drugs by consolidating their buying power. However, instead of driving costs down, PBMs appear to be doing the opposite. Over the past decade, independent pharmacies have experienced declining margins, due mostly to rising fees from these very same PBMs.

Now, however, Trxade is giving pharmacies a real opportunity to actually reduce purchase costs, along with other benefits. The integrated pharmaceutical services company provides its web-based purchasing platform for transactions between independent pharmacies and drug distributors. Known as the Trxade?Exchange, the platform provides small pharmacies with access to the wider pharmaceutical distribution network, allowing them to search for and view products from manufacturers, buying groups?and wholesalers on a real-time, continuous basis. In addition, through the Trxade E-Hub software, users of the Trxade?Exchange become members of a network of associated pharmacies, as well as gain access to warehousing and drug-delivery services.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

[QualityStocks]

QualityStocksNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Innovative Stock for Ads Program Contributes to Significant Sales Rebound

SRAX (NASDAQ: SRAX) recently held its FY 2019 and Q1 2020 results conference call (http://ibn.fm/YOcxB). An article further discussing the company’s results reads, “SRAX’s fiscal 2019 revenues of $3.6 million showed a 3% year-to-year increase while Q1 2020 sales fell to $350,000 relative to the $592,000 recorded in 2019, the latter decline largely a result of customers opting to defer their media spend to the second quarter. While first-quarter revenues tend to mark the seasonal low for the company, SRAX was able to launch new initiatives, namely its pioneering Stock for Ads program and BIGtoken Lighting Insights platform, both of which have contributed to a significant sales rebound in the second quarter. . . . A key driver for the company’s recent surge in marketing revenues has been its innovative Stock for Ads program, which has enabled customers to launch new media campaigns while paying with stock, thereby permitting companies to conserve cash. SRAX has sought to expand the scope of its program by tabling agreements with 31 banks and brokers, including the likes of B. Riley Financial Inc., who in turn have sought to promote and cross-sell SRAX’s marketing capabilities and Stocks for Ads program to their underlying client bases. Thus far this year, publicly listed U.S. companies have raised capital by selling stock at over twice the pace at which they did in 2019 (http://ibn.fm/AWQqH), a clear illustration of the popularity and potential of equity-based financing options.”

To view the full article, visit http://ibn.fm/qxXCs

About SRAX Inc.
SRAX is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends, and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

[QualityStocks]

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Ideally Positioned to Capitalize on Trump Administration’s Strategy to Revitalize Nuclear Fuel, Uranium Industries

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, is strategically positioned to capitalize on the Trump administration’s recently announced plan to revitalize the U.S. nuclear energy industry (http://ibn.fm/mvTrl). An article discussing the company reads, “Trump’s proposal to spend $150 million on a strategic U.S. uranium reserve will purchase uranium from domestic uranium producers that include Energy Fuels, the largest producer of uranium in the United States in recent years, and with assets that have accounted for over one-third of the nation’s natural uranium supply since 2006. With a licensed capacity of more than 8 million pounds of uranium per year, the company’s White Mesa Mill in Utah is the only conventional uranium mill in the country. Energy Fuels also owns and operates two ISR uranium facilities with an additional 3.5 million pounds of annual licensed capacity. . . . ‘Energy Fuels is the leading U.S. uranium producer, because we have proven assets with exceptional track records of production and environmental protection,’ UUUU CEO Mark Chalmers said in a recent corporate presentation (http://ibn.fm/L9sCM). ‘Energy Fuels has been the largest producer of uranium over the last few years, and we have more uranium production assets and capacity to increase production quicker and on a greater scale than any other producer in the United States by far.’”

To view the full article, visit http://ibn.fm/JAVql

About Energy Fuels
Energy Fuels is a leading U.S,-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the United States today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S., including several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU; the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

[QualityStocks]

Predictive Oncology Inc. (NASDAQ: POAI) CEO Discusses Acquisitions, Exclusive Database of Historical Tumor Data in Recent Interview

-POAI boasts unique historical database documenting actual drug responses of tumors – the largest in the world with over 150,000 tumors across 137 types
-Drug discovery funding for subsidiary Helomics planned through relationships with large pharmaceutical companies
-Company planning to acquire two new biological firms in the precision medicine space

Predictive Oncology Inc. (NASDAQ: POAI) is a knowledge-driven medicine company focused on applying data and artificial intelligence (AI) to cancer personalized medicine and drug discovery. In a recent interview (http://ibn.fm/fKe3u), POAI director and CEO Dr. Carl Schwartz discussed the acquisition of two biological firms, along with details about the company’s proprietary Helomics database. Comprised of hundreds of thousands of tumors across numerous cancer types, this key asset gives the company a significant advantage over its competitors in the precision medicine industry.

“Predictive’s major asset is its Helomics subsidiary and its proprietary database of over 150,000 cancer tumors covering over 137 types of cancers, with over 30,000 tumors related to ovarian cancer, which is sort of our specialty,” Schwartz stated of the database, which was created as a result of Helomics clinical testing of drug response and biomarker profiling of tumors ordered by a nationwide network of oncologists. “This is the largest inventory of its kind in the world.”
“The results of this tumor profiling were reported to the referring oncologist and used as a guide to individualizing the therapy of that patient,” Schwartz explained.

As part of its research into building AI-driven predictive models of tumor drug response and outcome (http://ibn.fm/kDL1Q), Helomics is generating additional, deeper genomic profiling of tumors in its collection and coupling this with a ‘reach back,’ to the originating oncologist to obtain the eventual outcomes of the patients over an extended period of time. The retrospective project with UPMC-Magee is one of the first such examples of this (http://ibn.fm/93NFU).

“I want to strongly emphasize that Helomics has a significant competitive advantage in obtaining outcome data via ‘reach back’,” stated Schwartz. “Unlike other companies that have to wait for up to 5 years or more for the patient to go through treatment to get quality outcome data, we have historical data from 15 plus years of clinical testing available now,” he emphasized, referring to the proprietary database and AI-driven predictive models that are of particular interest to pharmaceutical companies for drug discovery, giving POAI a significant advantage over other competitors in the precision medicine space.

POAI aims to fund the research activities of Helomics through a path similar to that taken by Foundation Medicine and its collaborative research relationship with Roche Pharmaceuticals. As its Helomics subsidiary continues its CancerQuest 2020 project with UPMC Magee Women’s Hospital, it is also collaborating with Interpace Diagnostics to build an AI-driven model of thyroid cancer and with ChemImage to investigate novel prostate cancer diagnostics.

The company has also invested in TumorGenesis, a second wholly owned subsidiary, in addition to engaging in the process of acquiring two other biological firms: Soluble Therapeutics and BioDtech.
The details discussed in the interview demonstrate POAI’s ability to validate its process, Schwartz noted, mentioning the company’s intent to “go to the pharma industry for major funding for development of AI-driven predictive models based on our extensive database.”

“We’re pretty excited about this. We think we’re going to finally get to the top of the heap here very shortly,” he concluded.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

[QualityStocks]

QualityStocksNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Initial Manufacturing Run of Revolutionary BaroShear(TM) K45 Processing System Completely Sold Out

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its receipt of an order for the 12th and final system scheduled to be built in the Company’s initial manufacturing run of its revolutionary BaroShear(TM) K45 processing system. The BaroShear K45, based on the Company’s proprietary Ultra Shear Technology(TM) (UST(TM)) platform, is a unique and powerful nanoemulsification system designed to resolve one of today’s most critical problems facing the global hemp-derived cannabinoid industry: how to make hemp-derived cannabinoid oil effectively soluble in water, to optimize absorption and bioavailability when consumed or applied. “We are extremely gratified and excited that the initial manufacturing run of our BaroShear K45 processing systems has sold out,” PBI CEO and President Richard T. Schumacher said in the news release. “We are also pleased that an impressive, up-and-coming company like Canopy CBD Farms was able to participate in and place an order for the final available unit in our first manufacturing run. We are confident that the BaroShear K45 will differentiate them in the marketplace with a substantial advantage over their competition.”

To view the full press release, visit http://ibn.fm/tECQz

About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold, Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

[QualityStocks]

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) on Pace to $11 Million in Annualized Sales

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced new projections for calendar Q2 sales. According to the update and based on its performance in April and May, the Company is now on pace for over $2.7 million in quarterly sales and approximately $11 million in annualized sales. “We believe we can drive further significant organic growth from current levels,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “Current performance is being driven by multiple factors, including volume, capacity and pricing, all aligning with a strong macro environment in the California cannabis marketplace. For some perspective, our June quarter is on pace to eclipse our March quarter by well more than a factor of 10x on the top line.”

To view the full press release, visit http://ibn.fm/tfigv

About Cannabis Strategic Ventures
Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing Cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

[QualityStocks]

QualityStocksNewsBreaks – Sugarmade, Inc.’s (SGMD) BudCars Achieves Record May Sales, Continues to See 10% Week-Over-Week Growth

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced record growth data for BudCars sales during the month of May. According to the update, the company posted nearly 30% sequential monthly growth over April sales and continues to see week-over-week sales growth at 10%, which suggests that BudCars will surpass $10 million in annualized sales by the month of August at its Sacramento location. “The top-line growth data has been extremely strong, and we have no reason to expect that to change. But it’s important that our shareholders understand that this is not a delivery service model,” Sugarmade CEO Jimmy Chan stated in the news release. “We aren’t simply earning a fee to deliver someone else’s inventory, and barely breaking even in the process. We are building an inventory at wholesale pricing, marking it up significantly, and pulling in very strong margins on every unit we deliver for sale.”

To view the full press release, visit http://ibn.fm/8k7aZ

About Sugarmade, Inc.
Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. Its Brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. For more information, please reference www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

[QualityStocks]

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Present at June 2020 Virtual Investor Summit

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that it will present at the Virtual Investor Summit, slated to take place June 9-12, 2020. Sigma is scheduled to present at 11:30 a.m. Eastern Time on Wednesday, June 10, and its President and CEO Mark Ruport will host virtual one-on-one investor meetings throughout the event. Conference participation is by invitation only and registration is mandatory.

InvestorBrandNetwork (“IBN”), in continued collaboration with InvestorSummit Group (“ISG”), is the official media partner and main sponsor for the June 2020 Virtual Investor Summit. In this capacity, IBN is providing wire-grade press releases, content syndication through 5,000+ distribution partners, visibility on a growing social media network of investor-oriented brands, and individual coverage of the participating companies through a highly interactive portal with one-click access to advanced market research tools.

To view the full press release, visit http://ibn.fm/aQGF6

About Sigma Labs
Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

[QualityStocks]

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Financial Highlights, Corporate Milestones for Q4 and FY 2020

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 (“FY 2020”) and management’s discussion and analysis (“MD&A”) for the three and twelve months ended March 31, 2020. “The global economic uncertainty brought on by COVID-19 capped off a volatile and challenging year for the cannabis sector. Despite these challenges, I am pleased with what our team achieved last year. However, we were not immune to this volatility, and following a strategic and operational review of our business, we recently announced a number of changes aimed at strengthening our financial discipline and positioning Canopy Rivers for sustained success moving forward,” Narbé Alexandrian, president and CEO of Canopy Rivers, said in the news release. “Reflecting on the past year, there were several significant achievements that make me optimistic for fiscal year 2021. First, our portfolio companies reached new milestones, including the licensing of PharmHouse, the expansion of TerrAscend’s U.S. operations, and ZeaKal’s successful trials of its PhotoSeed(TM) technology. Second, our graduation to the TSX and the launch of our Strategic Advisory Board signaled our company’s continued maturation. Finally, we made four new investments, including two in ag-tech, which we believe is a critical component of the value chain that is poised to disrupt the cannabis sector.”

To view the full press release, visit http://ibn.fm/eF5Si

About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

[Homebrew]

LOLOL....That dead Alonzo scam....

[QualityStocks]

International Spirits & Wellness Holdings Inc. (ISWH) is “One to Watch”

- ISW Holdings’ goal is to create successful companies and partnerships in various disrupting industries, including crypto, health care, wellness, supply chain management, adult beverages and more.
- Company leverages a combination of expertise, innovative resources, and software to build and guide brands toward success in their respective markets.
- Currently established as a technology, home health care and wellness company with a focus on reshaping different sectors by implementing innovative products and services to anticipate the future needs of the market.
- Recent joint venture with distributor of top-selling bitcoin mining equipment provides additional opportunity to take advantage of the incredible growth projected for the crypto market.
- ISW Holdings is uniquely positioned to tap into these markets due to its innovative approach and methodology that encompasses scaling of all operations throughout the essential stages of market development.

International Spirits & Wellness Holdings Inc. (OTC: ISWH) (“ISW Holdings”) is a brand management portfolio company with diverse partnerships that focus on growing businesses in multiple sectors, including crypto mining, renewable energy, home health care for the chronically ill, wellness and restoration, and the adult beverage industry, as well as early-stage operations in supply chain and logistics management. ISW Holdings operates as the nexus between its partnerships and their essential services for end users.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources, and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.

The Revolution

Positioned to create industry leaders, the company’s process entails strategic development and aggressive early growth of its partner brands to establish them as profitable and viable. ISW Holdings’ method is to nurture emerging partner brands through the essential stages of market development (from conceptualization to distribution) in sectors relevant to today’s marketplace. In addition, the company has a holistic approach to business development, with every strategy being delivered person-to-person from developers to end users.

The Challenge

The company’s goal is to turn its target audience into loyal consumers by ensuring transparency and a clear understanding of its products and services, thus creating visibility, credibility, and trust.

ISW Holdings’ Innovative Approach

ISW Holdings has diversified positions in its partnerships across technology, health care, wellness, renewable energy, and the adult beverage sectors. The company seek to provide industry leading modern solutions to its clients and sound business practices to its partners. This is accomplished through an early growth platform that cultivates its partnerships with the necessary resources and expertise to expand exponentially.

ISW Holdings’ Opportunity

The company’s opportunity is considerable. In the ever-changing high demand global marketplace, the need for timely innovation is critical. ISW Holdings’ portfolio brand management and creative thinking has allowed the company to develop and deploy enterprises that meet the needs of 21st century consumers. Through a fully vetted system of scalability, it is able to meet consumer demands with turn-key solutions.

Portfolio of Partnerships and Businesses

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. With partnerships that incorporate a depth of experience and industry insight, ISW Holdings has established itself as a portfolio company in technology, home health care, and wellness, with a focus on reshaping industry benchmarks.

Bit5ive

ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. As an official distribution partner of Bitmain (the industry’s leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean), Bit5ive is quickly becoming one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm sectors of the market.
Valued at $293.66 million in 2019, the bitcoin technology market is expected to reach $477 million by 2025, according to Mordor Intelligence. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.

Proceso, LLC

With a growing awareness of the importance of renewable energy worldwide, ISW Holdings has partnered with Proceso, LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining – two fields with a typically high energy demand.

Because crypto mining companies mostly operate outside of the United States with higher asset security risks, Proceso will assist these entities in securing their investments by providing a local source of power and infrastructure development. This is aimed at helping to reduce power consumption while creating secure crypto mining data centers in the U.S. For the gaming industry, Proceso is ready to tackle one of its biggest problems, latency, by building next-level infrastructure in key locations.

PHH – Home Health

PHH Paradigm Home Health answers the growing need for homecare services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care. PHH aims to be at the forefront of this change by offering quality care services infused with new emerging technologies.

ISW Holdings’ home health division is currently developing a pilot for on-demand health care, which consists of a dedicated, stable platform for different medical services. The platform will offer greater freedom of choice and transparency by allowing users to find outpatient clinics in their vicinities, compare costs, and pick the most suitable choices. PHH is also developing specialized technology and tools to support health care services outside of the bounds of specialized facilities by focusing on homecare facilities. This can not only shift the burden from hospitals and clinics, but also streamline specific parts of the health care process to enhance service and product distribution.

VOLUM

ISW Holdings’ logistics and supply chain management division was designed with the core goal of increasing supply chain efficiency as one of the key aspects of successfully growing any business. The VOLUM project’s focus is on identifying and then implementing advanced supply chain management strategies and methods that will enable ISW Holdings’ partner companies to scale and grow exponentially. To achieve this goal, the company develops and offers reliable systems and solutions that create innovative technologies and unmanned system operations for overall higher cost-effectiveness.

In the wellness sector, ISW Holdings has opted for a two-pronged approach to create effective, technologically advanced products, as well as developing innovative ways to educate customers about these products. To this end, ISW Holdings has partnered with BioPulse to achieve state-of-the-art research and development and production capabilities, as well as a direct route to market. The company plans to design and launch up to five unique brands in the wellness and restoration sector in 2020.

ISW Holdings is committed to developing product and service innovation in the consumer spirits and adult beverage industry, which faces increasingly strict regulations but growing demand. The company has been a key innovator in the industry for 25 years, having grown successful luxury brands such as Besado Tequila and others. By leveraging its expertise, ISW Holdings can help companies in the adult beverage industry increase production, streamline their supply chains, implement better processes, innovate their marketing strategies, expand into new areas, and build sustainable relationships with partners and customers.

Management Team

Terry Williams, Chief Executive Officer and Director
Terry Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance, and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, Williams amassed considerable corporate experience at United Parcel Service, where he took several logistical roles, including controller, where he managed more than 2,000 employees and a budget of more than $10 billion.

Williams also serves as president of Airwave Transportation and logistics and chief financial officer of AVI Insurance Caribbean, and he has worked in over 37 domestic and international airports. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce, Chairman
Alonzo Pierce is chairman of ISW Holdings and brings a wealth of business development and wealth management experience to the ISW team. He has spent the past 20 years building recognizable brands in multiple industry sectors. He has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands, including selling the world’s only black vodka. He served as regional director for Sapphire Brands, covering the Southwest and Southeast regions. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown, Secretary, Treasurer, Director
Kristina Mahoney-Brown is secretary and treasurer as well as director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

For more information, visit the company’s website at www.ISWHoldings.com

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

[QualityStocks]

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Rolls Out Cloud-Based Platform as Car Dealers Turn to Online Alternatives

- Faced with a dramatic drop in business, many dealerships have started providing customers with the possibility of conducting the entire vehicle purchasing process online
- Buyers can pick the car they want and even have it delivered for a test drive at their location
- The approach aligns with a growing automotive e-commerce trend, with consumers likely to purchase as many as 1.3 million vehicles annually online by 2035
- PowerBand’s cloud-based auto trading platform offers a convenient, efficient and safe option for buyers and dealers to buy, sell, lease and trade vehicles online, eliminating unnecessary middlemen

The coronavirus and technology have had the unexpected outcome of making the car buying process more efficient. Instead of browsing cars at a dealership, customers can find their dream car online and can complete the entire purchasing process online, from filling an application to requesting a car for a test drive to paying. This way of trading vehicles is fully in line with PowerBand Solutions Inc.’s (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) vision for automotive sales and purchases even before the pandemic hit – a streamlined interaction among participants without additional fees and unnecessary middlemen.

According to a recent McKinsey & Company report (http://ibn.fm/nh9jt), “The digital revolution is disrupting used-car retailing—for the better.” According to the report, “Online providers are beginning to dilute traditional used-car dealers’ positions and drive growth by empowering digitally savvy customers via three major capabilities:

- Complete end-to-end purchasing capabilities (desired by 59 percent of buyers),
- Extensive vehicle data and photos, along with effective search tools (desired by 64 percent of buyers), and
- Unique delivery options (desired by 28 percent of online buyers).”

The growing demand for online auto trading alternatives comes as ecommerce has already been booming in the industry in the last few years, changing the ways in which manufacturers, dealers, digital car sellers and other sell used and new cars. According to the Digital Commerce 360 Online Vehicle Shopper 2019 survey, conducted among 1,089 buyers, 49% are willing to purchase a new vehicle entirely online (http://ibn.fm/a8Msa).

Automotive ecommerce has generated online sales of approx. $14.6 billion in 2018 and has plenty of room for growth, having the potential to take up a sizable piece of the total automotive transaction market, which reached $1.1 trillion in 2019, according to the U.S. Department of Commerce (http://ibn.fm/vmAE3). The compound annual growth of digital sales was 7.61% from 2015-19 compared to 1.73% for total sales. According to Frost & Sullivan, this trend is likely to continue and consumers may purchase as many as 1.3 million vehicles annually online as soon as 2035 (http://ibn.fm/jWDBk).

PowerBand Solutions has been one of the first companies to embrace this trend. Developed by a team of experienced automotive, technology and finance experts, PowerBand’s cloud-based transaction platform was created around the core belief that consumers preferred to conduct automotive transactions online and avoid interactions with unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles from their smart phones or other devices, irrespective of their location and with never-seen-before speed, simplicity and cost-efficiency.

The company is currently rolling out its platform in the United States and to this end, it has partnered with Source Digital, a pioneer in immersive commerce through the use of digital media platforms and video content on the internet (http://ibn.fm/otBvE). This unique campaign will use Source’s patented technology to promote PowerBand’s platform inside popular video content with various channels and influencers in the U.S.

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Plans to Present at the June 2020 Virtual Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the update, Trxade Group management is scheduled to present at 10:20 AM ET (7:20 AM PT) on Tuesday, June 9, 2020, and will host virtual one-on-one investor meetings throughout the event. Conference participation is by invitation only and registration is mandatory. Please contact your conference representative for more information or to schedule a virtual one-on-one meeting.

To view the full press release, visit http://ibn.fm/T97q7

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

[QualityStocks]

Uber Technologies Inc. (NYSE: UBER) Rolls Out New Hourly Rate Option in Continuation of Pandemic, Social Unrest Measures

- Uber Technologies has used its open-access model for facilitating transit to revolutionize how the world’s citizens move around, operating its ride-sharing solutions in 67 countries
- The company recently introduced a pricing alternative that allows riders to pay for multiple stops at a single, hourly rate in select metropolitan cities beginning June 2
- The hourly rate replaces a model in which riders had to select new service after arriving at each destination, complicating the plans of those customers who needed to complete essential errands
- The new option is a timely response to the disruption of public transportation by forces including the deadly coronavirus pandemic, as well as the upheaval during rioting and social unrest in response to recent events within the United States

Pioneering transportation facilitator Uber Technologies Inc. (NYSE: UBER) is developing a new errand-running option for riders that shows the company’s responsiveness to customer needs at a time when numerous market disruption forces are challenging businesses’ efforts to keep operations in motion.

Uber’s announcement that it will allow riders to select a single $50 per hour rate with multiple stops in select cities (http://ibn.fm/HFj1v) provides an alternative for public transportation customers who’ve found their routines disrupted by daunting forces such as the ongoing global COVID-19 pandemic and recent rioting in many metropolitan cities.

“At Uber, we are always thinking about how we can make people’s lives easier by developing products that solve new challenges,” the company stated in a recent news release about family-centric changes to its meal delivery services (http://ibn.fm/rMlc6).

Uber has allowed riders to request multiple destinations in one trip since 2017 but it was previously necessary for them to re-request a new trip after visiting each location if they wanted to run errands to multiple stops, according to a report on the decision in The Verge (http://ibn.fm/pIrFu).

The single fee for multiple stops service rolled out June 2 in Atlanta, Chicago, Dallas, Houston, Miami, Orlando, Philadelphia, Phoenix, Seattle, Tacoma, Tampa Bay and Washington, D.C. It matches the riders with a driver who has a more spacious and newer model of vehicle that is eligible for Uber Comfort, according to the company.

Uber has introduced several new initiatives during recent weeks to support its own drivers as well as members of the general public attempting to continue performing essential tasks during the pandemic, which has seen a highly infectious and often deadly or debilitating virus spread throughout populations around the globe since the beginning of the year (http://ibn.fm/mS2px).

The company provided masks, hand sanitizer and cleaning supplies for its drivers, financial support for drivers who become sick, and information on navigating the varied regulations for public relief under the different governments where Uber’s drivers operate (http://ibn.fm/2MU2c). Riders are also required to wear masks, and drivers limit the number of passengers allowed per vehicle.

Recent unrest as a result of widespread anger over a black man’s death while in police custody led to the shutdown of public transportation in many of the United States’ metro areas, further disrupting transit (http://ibn.fm/uhiwH) while directing ridership to Uber drivers providing essential services (http://ibn.fm/Nh9Je).

Uber’s director of rider operations, Niraj Patel, said the new hourly multi-stop rate is “an additional earnings opportunity for drivers” in the company’s announcement, noting the customer will be asked to select how long the trip will last before confirming the ride and will end up paying for the time selected even if the trip actually takes less time.

Customers will also be charged a per-minute rate if their trips go over the time limit, or a per-mile rate for trips that go over the mileage limit. The company first tested the strategy in countries like Australia, Africa, Europe, and the Middle East, and plans to extend it to additional cities in the United States during the coming weeks as it determines the response from riders.

For more information, visit the company’s website at www.Uber.com

[QualityStocks]

QualityStocksNewsBreaks – Spectrum Global Solutions, Inc. (SGSI) Eliminates Over $500K of Convertible Debt

Spectrum Global Solutions (OTCQB: SGSI), a leading single-source technology and services provider specializing in next-generation energy management, professional engineering and communications network infrastructure solutions, today announced that it has instituted several cost cutting measures and was able to eliminate over $500,000 of convertible debt that would have been toxic to the company’s common stock. “The elimination of toxic debt, the tightening of our belts, and the strengthening of our balance sheet, is an on-going focus for the company and will continue to be so as we manage through these trying times,” Spectrum CEO Roger Ponder said in the news release.

To view the full press release, visit http://ibn.fm/dbAKD

About Spectrum Global Solutions

Spectrum Global Solutions (OTCQB: SGSI) is a leading single-source technology and services provider, specializing in next-generation energy management, professional engineering, and communications network infrastructure solutions. Spectrum’s highly scalable service platform model, proven out through engagements with tier-1 network operators in the United States, Canada, Caribbean, Europe, Africa and Asia uniquely allows for the bundling of disparate services and technology products with a single provider, simplifying network deployment and maintenance with a comprehensive, cost-competitive one-stop-shop solution. For more information, visit the company’s public filings at SEC.gov or its website at www.SpectrumGlobalSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to SGSI are available in the company’s newsroom at http://ibn.fm/SGSI

[QualityStocks]

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Discusses Strong Solution with Expected 50%+ Cost Advantage in Production of THC-V and Other Rare Cannabinoids

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced information on its Project Varin, a nearly complete research program implemented to develop novel production technologies for rare cannabinoids, including tetrahydrocannabivarin (“THC-V”), which is not scheduled at the federal level. According to the update, the program has produced meaningful technology breakthroughs resulting in several patent filings. The company has been able to leverage these technological developments to significantly reduce the cost of exotic cannabinoids on a per-serving basis resulting in a greater than 50% expected cost advantage. “We think we have rewritten the exotic cannabinoid cost equation via our Project Varin. The minor exotics represent a new cost challenge for the industry, and we believe we have developed a strong and defensible solution,” Arman Tabatabaei, CEO of Cannabis Global, stated in the news release. “Acquiring THC and CBD from plants within the Cannabaceae family is relatively easy as these cannabinoids are produced by nature in abundance. It is a very different issue relative to THC-V, CBN, and other exotics. With our patent pending technologies, we have been able to rewrite the cost equation for minor cannabinoids, while at the same time moving well beyond the purity possible from legacy technologies. While we are already at a 50% cost advantage to the competing technologies, most of which are still theoretical and not yet available on the market, we believe further travel down our cost curve is possible as we move into high volume manufacturing this month.”

To view the full press release, visit http://ibn.fm/aFYfy

About Cannabis Global, Inc.

Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission, trading with the stock symbol MCTC. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The company does not engage in the production, distribution, or sales of any controlled substances, including marijuana. The company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched is Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (“THC-V”) and to develop products based on this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

[QualityStocks]

QualityStocksNewsBreaks – Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Eyes Opportunity Amidst Increased Investment into Indonesia’s Battery Metals Supply Chain

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), an Indonesia-based company focused on developing battery mineral projects in the Asia-Pacific region, today noted reporting by the Financial Times that Huayou Cobalt (“Huayou”), “China’s top cobalt producer halts buying from Congo miners.” The Democratic Republic of Congo (the “DRC”) has been widely reported to represent 60% of global cobalt production. Huayou, which supplies cobalt to battery makers LG Chem of South Korea and CATL of China, as well as Chinese carmaker BYD and Germany’s Volkswagen, is the latest conglomerate to exit the DRC, joining Apple, Google and several auto manufacturers. According to the update, Huayou is looking to raise $870m in an effort to expand nickel and cobalt sulphate production in Indonesia, with its Morowali Industrial Park plant expected to produce at least 60,000 tonnes of annual nickel content within two years. “Cobalt remains an important ingredient in battery chemistries, and international markets are increasingly demanding conflict-free sources for the metal,” Bolt Metals CEO Ranjeet Sundher stated in the news release. “Bolt Metals believes Indonesia represents a unique opportunity to exploit cobalt as a byproduct of the country’s abundant nickel resources. Our flagship Cyclops nickel-cobalt asset has demonstrated strong results from 2018-19 drilling and benchmark analysis, providing an essential foundation for the eventual development of a pilot plant.”

To view the full press release, visit http://ibn.fm/2RRgu

About Bolt Metals Corp.

BOLT Metals is a Canadian-based exploration company focused on the acquisition and development of production grade nickel and cobalt deposits, key raw material inputs for the growing lithium-ion battery industry. For more information, visit the company’s website at www.BoltMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to PCRCF are available in the company’s newsroom at http://ibn.fm/PCRCF

[QualityStocks]

QualityStocksNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Update on Insolvency Proceedings Under the CCAA

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively “GGB”, the “company” or the “Applicants”) on Tuesday released an update on its insolvency proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”). As announced on May 20, 2020, GGB filed for insolvency protection under the CCAA and obtained an order from the Ontario Superior Court of Justice (the “Court”) granting protection for an initial 10 day period until May 29, 2020, as extended until June 12, 2020. According to the update, the Court, on June 2, 2020, granted a motion filed by the company and issued an order. The “Amended and Restated Order”: (i) extends the stay period until August 15, 2020; (ii) increases the amount of the Court-ordered charge over the Applicants’ assets, property and undertakings in connection with the Applicants’ debtor-in-possession financing agreement with All Js Greenspace LLC (“All Js”) (the “DIP Agreement”); (iii) approves the implementation of a sale and investment solicitation process (the “SISP”); and (iv) approves a stalking-horse agreement among the company, All Js and Capital Transfer Agency in its capacity as the debenture holder trustee of the company’s (A) US$45,500,000 aggregate principal amount of 15.00% secured convertible debentures that matured May 17, 2020 and (B) US$23,717,000 aggregate principal amount of 5.00% secured convertible debentures maturing in 2024 (All Js and Capital Transfer Agency in such capacities are collectively referred to as the “Secured Credit Bidders”) pursuant to which the Secured Credit Bidders would act as stalking-horse bidders under the SISP.

To view the full press release, visit http://ibn.fm/QK7ao

About Green Growth Brands Inc.

Green Growth Brands creates remarkable experiences in cannabis. The company’s brands include CAMP, The+Source, and 8 Fold. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

[QualityStocks]

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Acquires Soluble Therapeutics, Inc. and BioDtech, Inc.

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, on Tuesday announced the completion of the acquisitions of two wholly owned subsidiaries of InventaBioTech, Inc., Soluble Therapeutics, Inc. and BioDtech, Inc. Included in the acquisition were certain intellectual property relating to contract research organization (“CRO”) services and technology, certain equipment useful in such services and technology and all other assets of Soluble Therapeutics and BioDtech. In consideration, POAI issued 125,000 shares of common stock and waived all remaining amounts due and payable to the company under a secured promissory note of InventaBioTech in the principal amount of $1,070,000. “These two acquisitions meaningfully expand revenue and monetization prospects for our precision medicine business. First, the Soluble Therapeutics assets increase the company’s capabilities to provide services for the pharmaceutical and biotech industries and predict and provide the best formulation with the highest concentration and the most stable solution for protein and peptide-based drugs. Second, the company’s purchase of BioDtech’s assets provides it with ownership over BioDtech’s successfully developed test used to ‘unmask’ endotoxins, which allows a monitoring physician to perhaps change the strategy of treatment or treat the patient with antibiotics. These acquisitions will allow Predictive Oncology to further maximize opportunities within the company’s precision medicine business,” Predictive Oncology CEO and Director Dr. Carl Schwartz stated in the news release.

To view the full press release, visit http://ibn.fm/iQCUr

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

[QualityStocks]

Predictive Oncology Inc.’s (NASDAQ: POAI) Subsidiary a ‘Major Asset’ in Growing Precision Medicine Space

- POAI addresses pressing need for a multi-omic approach in field of precision medicine
- Global precision medicine market is expected to reach total market value of approximately $84 billion by 2026
- Predictive Oncology’s ‘claim to fame’ is its inventory of over 150,000 tumors covering over 137 types of cancer, with over 30,000 related to ovarian cancer

In the burgeoning world of precision medicine, Predictive Oncology Inc. (NASDAQ: POAI) appears ideally positioned to address one of the most pressing problems in the industry: the need for a multi-omic approach to precision therapy that may offer markedly improved patient outcomes over just genomics alone. POAI, a leader in the cancer precision-medicine field, has a “major asset” in its Helomics subsidiary, which specializes in ovarian cancer. Through its unique patient derived (PDx) platform, which tests the drug response and biomarker profile of the patient’s own tumor, and its vast database of historical tumor profiles, Helomics provides clinical decision support tools today to assist oncologists in individualizing cancer treatment.

Precision medicine is based on the idea of customizing health care, making medical decisions and selecting treatments, practices and prescriptions that are tailored to each individual patient rather than a recommended general treatment approach. A recent Acumen Research and Reporting article noted that the global precision medicine market is expected to reach total market value of approximately $84 billion by 2026 with anticipated CAGR growth of around 10% in terms of revenue between 2019 and 2026 (http://ibn.fm/vufVR).

That growth hasn’t gone unnoticed. Big pharma has invested heavily in precision medicine, focusing its efforts on genomics and “big data” to understand each patient’s genome in order to deliver targeted therapeutics. “Success rates for these targeted therapies are low, and uptake in clinical practice is patchy,” POAI reports on its website (http://ibn.fm/MywNK), noting a growing realization that “just genomics is not enough to achieve the promise of personalized therapeutics. A clear need has emerged for a multi-omic approach that may offer a much greater chance of success. However, few comprehensive, multi-omic data sets exist, and such data is difficult to access quickly as it is both costly and time consuming to initiate prospective data collection — especially in cancer.”

Multiomics, or the use of multiple omics technologies (i.e., genome, proteome, transcriptome, epigenome, microbiome, etc.) to study disease in a more comprehensive manner has significant implications in the world of health care – and Predictive Oncology owns powerful data and technology that may make the company a clear frontrunner in the precision medicine space.

“Predictive’s major asset is its subsidiary Helomics, and its claim to fame is its inventory of over 150,000 tumors covering over 137 types of cancer, with over 30,000 related to ovarian cancer, which is sort of our specialty. In fact, this is the largest inventory of its kind in the world,” POAI director and CEO Carl Schwartz stated in a news release (http://ibn.fm/e9EIC).

Furthermore, the data in POAI’s molecular information platform are highly differentiated, the company explained, containing both drug-response and biomarker data and with access to historical outcome data from these individual patients. Predictive Oncology is working to gather additional sequence data (mutation and gene expression) from these tumor samples, coupling this with its unique drug response profiles to build AI-driven predictive models of cancer that it believes will meet the unmet market need for a multi-omic approach to the development of new drugs and improve patient outcomes.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through the company’s Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy.

In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

[QualityStocks]

National Storm Recovery Inc. (NSRI) Positioning Itself as the Sustainable Green Team

- “Sustainability has become a business imperative for all companies,” reports WEF article
- NSRI’s Sustainable Green Team solutions are founded in sustainability, begin with the collecting of tree debris
- “The importance of our shared belief that we are ‘stewards of the environment’ should not be understated,” says Mulch Manufacturing CEO

A recent World Economic Forum (WEF) article (http://ibn.fm/SQk29) stated that “sustainability has become a business imperative for all companies.” National Storm Recovery Inc. (OTC: NSRI), a provider of storm/disaster recovery services, takes that imperative seriously and is committed to positioning itself as the Sustainable Green Team, as noted by CEO Tony Raynor (http://ibn.fm/Srkwk).

NSRI’s recent acquisition of Mulch Manufacturing was the latest step in National Storm Recovery’s commitment to providing environmentally friendly products to the public. “With Mulch Manufacturing’s national and international distribution, its sales contracts with many big box retailers, and the increase in production and packaging capacity it provides, this strategic acquisition has positioned us as the Sustainable Green Team,” Raynor stated in a news release.

National Storm Recovery’s Sustainable Green Team solutions are founded in sustainability. The company’s vertically integrated operations begin with the collecting of tree debris through its tree-services division and collection sites, then recycling the debris into a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers.

“The importance of our shared belief that we are ‘stewards of the environment’ should not be understated,” Mulch Manufacturing’s CEO Ralph Spencer agreed. “National Storm’s strategic partnership with one of the largest waste disposal companies in the country doesn’t just drive revenue while it secures mulch feedstock, the use of this feedstock has the environmental benefit of decreasing the volume of material that would otherwise continue to fill our nation’s landfills, and these are just [a few] examples of why this business combination makes so much sense.”

The WEF report, written by Karen Quintos, noted that “we know investment opportunity in sustainability is only growing bigger. The projects and programs being led by individual businesses are moving the needle. This is especially true when you combine sustainability investments with the unique products or services of your business, the talents of your people and the capabilities of your customers and partners. I call this your company ‘secret sauce.’ By bringing these resources together, today’s businesses have made significant progress in recovering materials, cleaning oceans and reducing our footprint.”

Certainly NSRI’s “secret sauce” is rooted in its commitment to sustainability, expert products and services, and the talents and skill sets of its people. “For more than 40 years, our team has dedicated our time to perfecting and honing our techniques,” states the NSRI website. “With the best equipment, most effective strategies, and a true dedication to customer service, we know we are the best team for the job.”

NSRI’s commitment is to environmentally beneficial solutions to tree and storm-waste disposal (http://ibn.fm/ri1RC). For investors, the company plans to expand its operations through a combination of organic growth, including its partnership with a nationally recognized waste disposal company and via strategic acquisitions. NSRI’s next-level experience with mulch manufacturing, treatment and caring for trees sets it on the right course for sustained growth.

For more information, visit the company’s website at www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

[QualityStocks]

QualityStocksNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTC: WLDFF) Announces $5.3 Million in Revenues for Q3

Wildflower Brands (CSE: SUN) (OTC: WLDFF) today announced $5.3 million in revenues in its third quarter, compared to $2.5 million in the previous year’s third quarter and $5.5 million in the second quarter. According to the update, revenues were slightly less than last quarter; however, even with unforeseen circumstances and business affected by Covid-19, Wildflower was able to operate with a net gain of $101,435 compared to a loss of $(1,019,862) in the third quarter of 2019. Wildflower’s U.S. operations have been curtailed due to the closure of many retail locations where the Company’s products are sold. Manufacturing and sales activities have been scaled back to align Wildflower’s resources with the current business environment. The Company is also investigating government sponsored assistance programs to support its employees and their families.

To view the full press release, visit http://ibn.fm/1NsnM

About Wildflower Brands Inc.

Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy, toward becoming a global wellness leader. For more information about Wildflower Brands, visit www.WildflowerBrands.co. To learn, engage and shop for wellness products visit www.BuyWildflower.com.

[QualityStocks]

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Subsidiary to Provide Consumers, Dealers Access to Extensive Lease Financing

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) this morning announced that MUSA Auto Finance, LLC (“MUSA”), its 60% controlled leasing platform in the United States, is expected to commence lease originations on its proprietary cloud-based platform for consumers and auto dealers in June. MUSA will enable consumers and dealers to access extensive funding facilities from national financial institutions through the platform, which is accessible on smart phones and other digital devices. In addition, the company has agreed to make PowerBand’s virtual transaction platform, which includes MUSA, available to thousands of dealerships working with RouteOne LLC in the United States and Canada. RouteOne offers a broad range of finance and insurance tools, including credit applications, eContracting, digital retail and compliance. “This is a major advancement for MUSA and PowerBand,” MUSA Auto Finance CEO Jeff Morgan stated in the news release. “We have a proprietary auto lease platform that we believe is the first of its kind, and now we are finalizing exclusive agreements, with national financial institutions, so we can roll out our technology to dealers and consumers nationally.”

To view the full press release, visit http://ibn.fm/mwt3t

About PowerBand Solutions Inc.

PowerBand Solutions, listed on the TSX Venture Exchange and the OTCQB markets, is a fintech provider disrupting the automotive industry. PowerBand’s integrated, cloud-based transaction platform facilitates transactions among consumers, dealers, funders and manufacturers (“OEMs”). The platform enables these entities to buy, sell, trade, finance and lease new and used, electric and nonelectric vehicles on smartphones or other online digital devices from any location. PowerBand’s transaction platform —trademarked under DRIVRZ — is being made available across North American and global markets. For more information, visit www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

QualityStocksNewsBreaks – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering

Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently announced its entry into an agreement with Canaccord Genuity Corp. (the “Lead Underwriter”). Under the arrangement, the Lead Underwriter agreed, on behalf of a syndicate of underwriters, to purchase, on a bought deal basis per the filing of a short form prospectus, an aggregate of 4,500,000 units, each at a price of $2.50, for aggregate gross proceeds of $11,250,000 to the Company. Cardiol intends to use the proceeds to support commercialization of its pharmaceutical cannabidiol products, its ongoing research and clinical development programs focused on heart failure, additional product development, as well as for general corporate purposes.

To view the full press release, visit http://ibn.fm/Pe1B9

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (“CBD”) products and developing innovative therapies for heart diseases, including acute myocarditis and other causes of heart failure. The Company’s lead product, CardiolRx(TM), is formulated to be the most consistent cannabidiol formulation on the market. CardiolRx is pharmaceutically produced, manufactured under cGMP, and is THC free (<5 ppm). The Company also plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is pursuing distribution opportunities in Europe and Latin America.

In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated annual healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visit CardiolRX.com.

[QualityStocks]

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Engages PCG of New York for IR and Digital Marketing Services

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Monday announced that it has retained PCG Advisory, Inc. (“PCG”) of New York, to provide investor relations and digital marketing services to the Company in compliance with regulatory guidelines. According to the update, PCG’s sectors of deepest experience include life sciences, technology and cannabis, and it reaches thousands of individual, retail and institutional investors daily using the latest social media and digital marketing techniques. PCG will develop a comprehensive strategy to increase investor awareness of Lexaria, amplify market visibility, and introduce the Company to its proprietary investment community network that includes institutional funds, banks, analysts and brokers.

To view the full press release, visit http://ibn.fm/g0sOc

About Lexaria

Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

[QualityStocks]

QualityStocksNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Posts Q1 2020 Financial Results

Exro Technologies (CSE: XRO) (OTCQB: EXROF), a clean-tech company committed to transforming energy conversion to enhance the performance, efficiency and longevity of electric motors, on Monday announced financial and operational results for the three months ended March 31, 2020. Per the release, the company incurred a comprehensive loss of C$1,525,182 during the quarter. The company also reported that it incurred C$175,882 in research and development for the quarter, which primarily represents materials used for development of its technology as Exro continues to advance toward its goals for commercialization. “Exro is in full force at commercializing its patented Coil Switching Technology. We engaged multiple partnerships with manufacturers during the first quarter such as Finland’s Aurora Powertrains Oy (“Aurora”) and Clean Seed Capital Group Ltd. (“Clean Seed”) along with the partnerships from 2019, Motorino Electric Bike, Potencia and Templar Marine. We are in talks with several potential partners to build prototypes that will be implanted into the field,” Exro Technologies CEO Sue Ozdemir stated in the news release. “We are also in works to open a 6,500 sq. ft. innovation center in Calgary, Alberta, to demonstrate how the company dramatically improves the performance of the world’s electric motors. The Exro Innovation Center (“EIC”) will also increase the company’s laboratory space, to expand its service capabilities to customers and showcase where Exro’s technology can be applied to key sectors of the economy. The EIC will also host collaborative events to explore advances in energy consumption and power electronics innovations, with participants from Calgary, across Canada and around the world.”

To view the full press release, visit http://ibn.fm/guZaZ

About Exro Technologies Inc.

Exro is a clean-tech company that has developed a new class of control technology for electric powertrains. Exro’s advanced-motor control technology, or Coil Driver, expands the capabilities of electric motors and powertrains. Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real time so that torque demand and efficiency are optimized.

The limitations of traditional electric machines and power technology are becoming more evident. In many increasingly prominent applications, traditional methods cannot meet the required performance. This means either oversizing the equipment, adding additional motors or implementing heavy mechanical-geared solutions. Exro offers a new solution for system optimization through implementation of its technology, which can yield increased drive cycle efficiency, reduced system volume, reduced weight, and expanded torque and speed capabilities. Exro allows the application to achieve more with less energy consumed. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

[QualityStocks]

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Inks Licensing, Distribution Agreement with FILMHUB

Vertically integrated motion-picture production company The Movie Studio (OTC: MVES) announced in April that it signed a licensing and distribution agreement with FILMHUB, an online marketplace for film creators and streaming services (http://ibn.fm/LLdvn). An article discussing the company reads, “In addition, the Movie Studio will license its catalog to FILMHUB for distribution by way of its online film marketplace. . . . ‘We are excited to begin to offer hundreds of titles on our OTT platform in addition to licensing our titles to FILMHUB and its associated OTT partners,’ MVES studio president and CEO Gordon Scott Venters stated in a news release. ‘As we continue to grow shareholder equity by acquisition and strategic partnerships, we believe FILMHUB is a perfect partner for continued growth. We look forward to a long and mutually profitable and beneficial partnership.’ . . . FILMHUB of Santa Monica, California, has its modern, technology-driven B2B (business to business) marketplace for filmmakers to reach streaming channels worldwide. FILMHUB has more than 12,000 titles available for licensing to more than 100 channels.”

To view the full article, visit http://ibn.fm/H9UwY

About The Movie Studio Inc.

The Movie Studio operates as a vertically integrated motion-picture production and distribution company. The company acquires, develops, produces and distributes independent motion-picture content for worldwide consumption via theatrical release, video on demand, foreign sales and various media devices. MVES is disrupting traditional media-content delivery systems with its digital business model of motion picture distribution and intends direct server access of its content with geofractured territories for worldwide distribution. The company was formerly known as Destination Television Inc. and changed its name to The Movie Studio Inc. in November 2012. The Movie Studio Inc. was founded in 1961 and is headquartered in Fort Lauderdale, Florida. For more information, visit the company’s website at www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

[QualityStocks]

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Applies Unique Database to Improve Cancer Outcomes

Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. An article discussing the company reads, “With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own living tumor to address challenges oncologists often face when assessing patients and individualizing treatments. The clinically validated (in ovarian cancer) cell-based functional platform is in use today and profiles patient tumors, identifying key biomarkers and how the tumor responds to drugs and helps the oncologist determine a tailored therapy for that patient. . . . Helomics’ is building AI-driven predictive models by leveraging a unique database of 150,000 tumor genomic and drug response profiles gathered from over 15 years of clinical testing using its TruTumor platform, access to over 15 years of outcome data from a national network of oncologists, plus a physical biobank of tumor samples that is being sequenced as part of its CancerQuest 2020 initiative (http://ibn.fm/B9mmE) to generate rich genomic profiles.”

To view the full article, visit http://ibn.fm/4G1qF

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

[QualityStocks]

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical teleconferencing visits through Bonum Health and prescription delivery through the company’s DelivMeds same day/mail-order pharmaceuticals service each month under the standard membership rate. . . . ‘With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier of self-doubt and complacency in the current climate of worldwide viral infections,’ the company stated in a news release (http://ibn.fm/BrWLY).”

To view the full article, visit http://ibn.fm/UaikR

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy-delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

[QualityStocks]

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) and Source Digital Join Forces to Promote Auto Trading Platform

- Source Digital has worked with numerous Fortune 500 companies to help create a more effective video advertising experience
- Company’s innovative advertising platform is designed to increase customer engagement and ROI
- PowerBand’s cloud-based auto trading platform offers a convenient, efficient and safe option for buyers and dealers to buy, sell, lease and trade vehicles online, eliminating unnecessary middlemen

Through a recently announced partnership, PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) and Source Digital will join forces to promote PowerBand’s innovative auto trading platform that provides car buying and financing trucks with never-seen-before simplicity, speed, and cost-efficiency. The trading platform will be promoted via Source Digital’s unique in-video advertising platform, designed to provide an enhanced viewer experience, help customers improve their return on investment while offering an overall more engaging and enjoyable experience for customers and users.

Source Digital is a pioneer in immersive commerce, essentially revolutionizing video advertising with its platform. The company has made great efforts to transform video advertising considering how disengaged and impatient viewers have become with it. Source spent seven years working on a video advertising system that engages viewers without disrupting their experience. The company has worked with numerous Fortune 500 companies to create a more engaging and effective video advertising experience. Its network can pull targeted content from multiple sources including sports channels and influencers.

“We are happy to announce our partnership with Powerband Solutions,” Source Digital CEO Hank Frecon said, according to a company news release (http://ibn.fm/vtQI3). “We trust that we will bring value to their system and provide a better user experience at the same time.” Under the agreement, Source Digital will enhance PowerBand’s platform by helping create a more engaged experience for viewers. Source’s advertising platform will deliver the entire car loan approval process into consumer videos.

The partnership will help PowerBand Solutions roll out its platform across the United States. The cloud-based auto-transaction platform successfully addresses a growing demand to sell and buy vehicles online to enhance convenience and adhere to the social distancing restrictions enforced by the ongoing pandemic. According to the Digital Commerce 360 Online Vehicle Shopper 2019 survey, 49% of buyers are willing to purchase a new vehicle entirely online, while Frost & Sullivan estimates that consumers will be able to purchase as many as 1.3 million vehicles online annually as soon as 2035 (http://ibn.fm/QCgmZ).

Developed by a team of experienced automotive, technology and finance experts, PowerBand Solutions’ platform was created around the core belief that consumers preferred to conduct automotive transactions online and avoid interactions with unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles with never-seen-before simplicity, speed and cost-efficiency from their smart phones or other devices, irrespective of their location.

PowerBand has already successfully launched and conducted “virtual” auctions in the United States together with and D2D Auto Auction LLC. D2D is co-owned by PowerBand and Arkansas-based financier Bryan Hunt, director of J.B Hunt Transport. The highly successful virtual auctions testify to the speed and efficiency of D2D’s unique transaction platform (http://ibn.fm/rTPEW).

The company is working on commercializing its platform to consumers and automotive dealers and to this end, it has secured a commitment of up to $10-million in investment from Texas-based D&P Holdings Inc. – one of the largest administrators of automotive warranty and insurance products in the United States, working with more than 850 dealerships nationwide (http://ibn.fm/ATuWl).

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

[QualityStocks]

Sigma Labs Inc. (NASDAQ: SGLB) Stands to Benefit from Post-Epidemic Trends Aimed at Strengthening Manufacturing, Supply Chain

-COVID-19 exposed weaknesses in manufacturing, supply chain spaces; 3D printing offers ideal solution
-3D-metal-printing presents its own mechanical hurdles, including quality issues undetected until postproduction
-SGLB’s patented PrintRite3D(R) software provides solution to costly quality-control challenges that impede manufacture of precision 3D-metal parts

Among the many changes wrought by COVID-19, those within the manufacturing and supply chain sectors will likely be far reaching and long lasting. The epidemic has exposed fundamental weaknesses in the system, some of which may be solved through advanced software and technologies, including 3D metal printing. Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality-assurance software in the commercial 3D-metal-printing space, may benefit from the trend.

“3D printing has come a long way in recent years, with manufacturing times improving,” a recent Forbes article reads (http://ibn.fm/OB0WW). “The time it takes to print items depends on both the quality of the printer as well as the complexity of the item being printed. As we enter a new era with COVID-19 continuing to disrupt supply chains and causing shortages of essential medical equipment, the 3D printing community is stepping in to help.”

Another article, published by MarketWatch, makes a similar observation. “Out of necessity, manufacturers in the new normal will build factories much closer to where critical parts are needed, reduce the human workforce, and rely more on software and efficiency technologies like 3D printing,” the article reads (http://ibn.fm/EfzTG). “At the epicenter of this sea of change is Sigma Labs, with its revolutionary patented technology that detects and identifies defects and anomalies in real time during the 3D printing process of metal, paving the way for scalability and economic efficiency.”

Both articles point out that additive manufacturing, or 3D printing, speeds production, allows flexibility, and brings new ideas to market quicker at lower cost. However, the new technology is not perfect. “Commercial 3D metal printing is gaining vital importance in the entire global manufacturing sector – yet the efficiency it yields is not without challenges,” the MarketWatch article notes. “A myriad of variables from machines to materials create production hurdles in metal additive manufacturing.”

Among those problems is the fact that the newly printed parts don’t always meet precise specifications. Previously, 3D-metal-printing manufacturers have had to rely on post-production inspection techniques to detect these imperfections, which are both costly and wasteful, since the problem isn’t discovered until the printing is complete, rendering the part unusable.

“With its patented PrintRite3D(R) software, Sigma Labs presents a solution to the costly quality-control challenges that impede the volume manufacture of precision 3D metal parts,” the article continues. “In doing so, Sigma’s software could easily become indispensable in the global efforts to meet the manufacturing challenges of post COVID. The company’s breakthrough software has the potential to bolster and broaden commercial metal-additive manufacturing by enabling for the first time cost-effective, nondestructive quality assurance during the production process. PrintRite3D(R) is the leading technology in identifying and classifying defects and anomalies in-process and allows for errors to be corrected in real time — even remotely.”

Sigma Labs Inc. is a leading provider of quality-assurance software to the commercial 3D-metal-printing industry under the PrintRite3D brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D-metal, advanced-manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB